279.70
+0.8(+0.29%)
Currency In INR
Address
BSEL Tech Park, B-Wing
Navi Mumbai, 400703
India
Phone
91 22 6794 2222
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1491
First IPO Date
January 29, 2007
| Name | Title | Pay | Year Born |
| Mr. Pradeep Patni | Chief Executive Officer of India Formulation Business | 0 | 1960 |
| Mr. Jitendra Jayantilal Gandhi | Compliance Officer & Company Secretary | 3.82M | N/A |
| Mr. Vinod R. Verma | Chief Financial Officer | 13.84M | N/A |
| Dr. Shireesh Bhalchandra Ambhaikar | President of Operations - API Business | 14.98M | N/A |
| Mr. Krishnamoorthy Chandran | Vice Chairman | 0 | 1958 |
| Mr. Prakash Venkataraman B.E., MBA | Head of API Business | 0 | 1966 |
| Mr. Mohan Kumar Rayana | Whole Time Director | 0 | N/A |
| Mr. Nanasaheb Gunjal | Senior Vice President of QA,QC & RA | 0 | 1963 |
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
